Veeva’s stock dips after Goldman Sachs cuts rating to Sell


Veeva Systems sign near cloud-computing company focused on pharmaceutical and life sciences industry applications

Michael Vi

Shares of Veeva Systems (NYSE:VEEV) fell about 4% premarket on Thursday after Goldman Sachs downgraded the stock to Sell from Buy, citing medium-term risks.

The firm also lowered its price target on the shares to $200 from $261.

Analysts led by Gabriela Borges


Leave a Comment